Dan R. Robinson
Biochemistry, Genetics and Molecular Biology · University of Michigan
Publications
441
Citations
32,032
Est. group size
~44
Recurring co-author estimate
Active years
54
Publishing since 1973
Typically publishes in teams of ~21 · 8% small-team papers (≤3 authors) · across 10 venues
- Data from Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer
2023
- Supplementary Data from Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer
2023
- Data from Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer
2023
- Supplementary Data from Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer
2023
- Data from Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition
2023
- Data from Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition
2023
- Xylitol nasal preparations in sinonasal disease: a literature review and meta-analysis
Australian Journal of Otolaryngology · 2022
- Explainable AI in Futures
SSRN Electronic Journal · 2022
- Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer
Cancer Research · 2021
- Abstract PS17-03: Recurrent active <i>ESR1</i> fusions render a diagnostic transcriptional signature in metastatic breast cancer
Cancer Research · 2021
- Abstract 742: The integration of a structure-function rule and a transcriptional signature to assign <i>ESR1</i> fusion activity in metastatic breast cancer
Cancer Research · 2021
- Index of Cancer-Associated Fibroblasts Is Superior to the Epithelial–Mesenchymal Transition Score in Prognosis Prediction
Cancers · 2020
- Abstract P6-04-04: Functional characterization of <i>ESR1</i> fusions in breast cancer
Cancer Research · 2020
- Abstract 5677: Recurrent transcriptionally active <i>ESR1</i> fusions render therapeutic vulnerabilities to kinase inhibition in advanced breast cancer
Cancer Research · 2020
- Publisher Correction: The long tail of oncogenic drivers in prostate cancer
Nature Genetics · 2019
- Cancer Research×20
- Journal of Clinical Oncology×14
- JCO Precision Oncology×7
- Clinical Cancer Research×5
- Oncotarget×5
- Yi‐Mi Wu
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Marcin Cieślik
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Sree M Lanka
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Ping Qiu
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Robert D. Patton
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile